nanosynth group appoint Andrew Stedman and Peter Gray to the board

nanosynth Group plc (LON:NNN), the AIM quoted company specialising in the synthesis and application of nanoparticles to create new and improve existing products, has announced the appointments of Andrew Stedman as Chief Financial Officer and Peter Gray as an independent Non-Executive Director of the Company with immediate effect. Both positions will be board roles.

Andrew Stedman was appointed as the Company’s non-board Chief Financial Officer on 7 February 2022. Andrew has considerable experience and a proven track record of driving incremental cash value whilst delivering on strategic growth strategies, across numerous market sectors.  Andrew has previously led commercial finance, transformation, and product launches at listed Company’s such as Ricoh PLC and Dixons Carphone PLC.  Andrew brings the experience of a well-rounded and highly commercial finance leader with substantial M&A and deal exposure, skills closely aligned to our strategic objectives.

Peter Gray has a wealth of experience in corporate and M&A transactions. Peter graduated with degrees in Law and Commerce from Melbourne University in 1984 and then worked in the corporate finance department at Minter Ellison (Melbourne) before moving to Clifford Chance, the leading international law firm. After completing an MBA in Finance, Peter then joined Cavendish Corporate Finance in 1994 which has subsequently merged with small and mid-cap listed corporate finance and broking house finnCap which listed on AIM in December 2018. Peter is currently employed as a partner of finnCap Cavendish a trading name of finnCap Group plc. Peter is also a frequent lecturer and author on the subject of mergers and acquisitions.

The following information is disclosed pursuant to Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies in relation to Andrew John Christian Stedman (aged 43):

 Current directorships and/or partnerships:Former directorships and/or partnerships (within the last five years):
Ertominiz LimitedThorin Ltd

The following information is disclosed pursuant to Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies in relation to Peter James Gray (aged 61):

 Current directorships and/or partnerships:Former directorships and/or partnerships (within the last five years):
NoneCavendish Corporate Finance (UK) Limited

Peter Gray was previously an LLP member of Cavendish Corporate Finance LLP.

Mark Duffin, Chief Executive of nanosynth Group, commented:

“We are delighted that both Andrew and Peter have agreed to join the Board and, on behalf of all the Directors, we welcome them and very much look forward to working with them. The pair bring extensive experience and I have no doubt that they will quickly become extremely valuable members of the Board.”

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    X
    LinkedIn
    Nanosynth Group plc

    More articles like this

    Nanosynth Group plc

    Nanotechnology in cosmetics and cosmeceuticals

    Nanoparticles (NPs) are defined as materials with dimensions smaller than 100 nm and presenting various shapes, i.e., spheres, rods, dendritic shapes, etc. This definition is accepted by the European Union (EU) Commission. It should be noted, however,

    Nanosynth Group plc

    Nanoparticles in cosmetics

    Nanoparticles are particles that are smaller than 100 nanometer (1/10,000 millimeter) which is about 40,000 times thinner than a hair. There are two forms of nanoparticles: soluble and biodegradable nanoemulsions such as liposomes and insoluble nanopigments

    Nanosynth Group plc

    What nanoparticles do to our cells

    During the past few years, nanoparticles have been increasingly present in our everyday lives. To gain a better understanding of their health impacts, several studies have focused on the effects they have on our bodies and

    Nanosynth Group plc

    Role of nanotechnology for design and development of cosmeceutical

    Nanotechnology is an innovative area of science that includes the design, characterization, production, and application of materials, devices and systems by controlling shape and size at the nanometer scale (1–100 nm). Nanotechnology incorporation in cosmetic formulation

    Nanosynth Group plc

    Nanotech could be the next frontier of drug delivery

    Nanotechnology is an emerging and rapidly developing area in the pharmaceutical and medicinal field. For example, nanoparticles can be used as drug delivery systems. Nanotechnology could help overcome the limitations of conventional drug delivery such as biodistribution and

    Nanosynth Group plc

    Nanoparticles to aid cancer treatments

    Conventional therapies in cancer treatment face challenges in delivery of drugs in the body and just the quantity needed, due to the toxic nature of the medicines used that have unwanted side effects. Nanomaterials have ‘enormous’

    Nanosynth Group plc

    Nanoparticles: Emerging trends in human health and environment

    As part of the ongoing Govt of India initiative “Azadi ka Amrit Mahatosav”, the Indian Journal of Biochemistry and Biophysics (IJBB), CSIR-National Institute of Science Communication and Policy Research (NIScPR), New Delhi, has brought out its

    Nanosynth Group plc

    Nanoparticles that self-assemble inside cells to fight cancer

    Inspired by viral replication, researchers developed a therapy that commandeers biological processes to craft nanoparticles within macrophages to aid in cancer therapy. Through self-assembly, the nanoparticles address some of the delivery issues plaguing present renditions of nanomedicines,

    Nanosynth Group plc

    nanosynth Group getting a huge amount of traction (LON:NNN)

    nanosynth’s Mark Duffin discusses what the company does, the Volz trial results, joint venture with a global wellness company and what investors can expect for the rest of the year in this exclusive interview with DirectorsTalk.

    Nanosynth Group plc

    Nanotechnology in the nutricosmetics industry

    Nanotechnology for Nutricosmetics Nanocarriers are ubiquitous within nanomedicine; however, with skin quality and health in high demand for consumers, these fields have overlapped. The use of nanotechnology and nanoformulations as delivery systems for improving the performance

    Nanosynth Group plc

    Nanotechnology in cosmetics

    Nanotechnology is the science of manipulating atoms and molecules in the nanoscale – 80,000 times smaller than the width of a human hair. The world market for products that contain nanomaterials is expected to reach $2.6